Compare
Movado Group Inc vs Cadre Holdings, Inc. vs TransMedics Group, Inc. vs Allient Inc
| Latest fiscal year | Movado Group Inc MOV | Cadre Holdings, Inc. CDRE | TransMedics Group, Inc. TMDX | Allient Inc ALNT |
|---|---|---|---|---|
| Year ended | 2026-01-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $671.31M | $610.31M | $605.49M | $554.48M |
| Revenue growth (YoY) | +2.7% | +7.5% | +37.1% | +4.6% |
| Gross margin | 54.2% | 42.5% | 59.9% | 32.8% |
| Operating margin | 4.4% | 11.0% | 17.9% | 7.9% |
| Net margin | 4.0% | 7.2% | 31.4% | 4.0% |
| Net income | $26.55M | $44.14M | $190.29M | $22.03M |
| EPS (Diluted) | $1.17 | $1.02 | $4.87 | $1.32 |
| Operating cash flow | $57.92M | $63.70M | $192.84M | $56.67M |
| Free cash flow | $53.41M | $56.85M | $133.59M | $49.69M |
| Cash & equivalents | $230.54M | $122.90M | n/a | $40.70M |
| Total assets | $742.62M | $770.03M | $1.07B | $577.60M |
| Total liabilities | $232.36M | $452.23M | $595.27M | $276.14M |
| Shareholders' equity | $510.26M | $317.80M | $473.10M | $301.45M |
| Return on year-end equity | 5.2% | 13.9% | 40.2% | 7.3% |
| Shares outstanding | n/a | 42.16M | 34.27M | 16.94M |
Revenue, most recent five fiscal years
| Fiscal year | Movado Group Inc | Cadre Holdings, Inc. | TransMedics Group, Inc. | Allient Inc |
|---|---|---|---|---|
| Latest | $671.31M Ended 2026-01-31 | $610.31M Ended 2025-12-31 | $605.49M Ended 2025-12-31 | $554.48M Ended 2025-12-31 |
| 1 year earlier | $653.38M Ended 2025-01-31 | $567.56M Ended 2024-12-31 | $441.54M Ended 2024-12-31 | $529.97M Ended 2024-12-31 |
| 2 years earlier | $664.39M Ended 2024-01-31 | $482.53M Ended 2023-12-31 | $241.62M Ended 2023-12-31 | $578.63M Ended 2023-12-31 |
| 3 years earlier | $744.21M Ended 2023-01-31 | $457.84M Ended 2022-12-31 | $93.46M Ended 2022-12-31 | $502.99M Ended 2022-12-31 |
| 4 years earlier | $732.39M Ended 2022-01-31 | $427.29M Ended 2021-12-31 | $30.26M Ended 2021-12-31 | $403.52M Ended 2021-12-31 |